A third member of a panel of outside advisers to the U.S. FDA has resigned in protest over the agency's decision to approve Biogen's Alzheimer's disease treatment despite the committee's recommendation against doing so https://t.co/1gH6DmJaqe pic.twitter.com/tTQa8KjCKR— Reuters (@Reuters) June 10, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


